drugset / Trial / NCT04685031

Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis

NCT04685031

Phase 1/2 Unknown 110 enrolled Komar University of Science and Technology
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of this study was to determine the effect of Clobetasol ointment with nitroglycerin ointment on the prevention of superficial phlebitis caused by cannulation. This clinical trial was conducted on 110 patients admitted to the surgical ward, in three groups of Clobetasol, nitroglycerin, and control. The data collection tools included demographic information, information about intravenous treatment and phlebitis measurement scale. In the intervention groups, after venipuncture, 1.5 cm (about 2 g) of ointment was applied in the distal part of the Angio catheter and the site was dressed with sterile gauze. In three time periods of 24, 48 and 72 hours from the time of venipuncture.

Timeline

Start
2021-02-01
Primary completion
2021-04-01
Completion
2021-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Clobetasol Small molecule 2 g Topical
Subject Nitroglycerin Unknown 2 g Topical

Indications